Regulatory Affairs: CMC

Explain the CMC section, a required part of the pharmaceutical application, showing controlled processes and facilities that ensure safety, identity, strength, quality, and purity of drug substances and products.

Explore how the pharmaceutical application drives regulatory approval by authorities, enforce the CMC section for manufacture and control, and keep it a living document through change control and post-approval submissions.

Explore the regulatory history of CMC and how tragedies involving drug products and devices shaped quality standards, enforcement, and global market practices.

Track the formation of the Bureau of Chemistry to regulate drugs and food, the Wiley Act, and 1906 food and drugs act addressing adulteration, misbranding, labeling sparked by the jungle.

Grants FDA authority to regulate safety of food, drugs, and cosmetics in the American marketplace under 1938 act, and institutes the new drug application (NDA) to document safety and efficacy.

Navigate EU legislation for medicinal products, covering the rules governing human and veterinary use, regulatory guidelines, GMP, pharmacovigilance, and clinical trial standards.

Explore the international council for harmonization of technical requirements for pharmaceuticals for human use, a joint regulators and industry initiative creating harmonised guidelines for drug development, safety, quality, and efficacy.

Explore EU pharmacopoeia standards and the European Pharmacopoeia of the Council of Europe, the official EU pharmacopoeia listing active substances and excipients, with local pharmacopoeias in the UK and Germany.

Understand how US CMC regulations are enforced by the FDA, authorized by Congress, and how compendia monograph requirements apply to USP and NF. Explore Japan's official pharmacopoeia published by PMDA.

Explains CMC within a drug application, detailing CTD content requirements for different markets and health authority guidance documents that describe organizational, structural, and high level content requirements.

Understand how CMC module 3 governs chemistry, manufacturing and controls for drug substances and products, ensuring safety, efficacy, and consistent cross-referenced impurity and toxicology data.

The CMC dossier reflects the proposed manufacturing process and drug product test methods, tightly controlled by quality systems and GMP, with changes assessed to ensure registration compliance.

GMP guidelines originated in the US in 1966 and are widely adopted worldwide, aligning with CFR 210 to 11 and 820 for drugs and devices, plus Q7 guidance.

Apply a quality management system based on ISO standards to plan, execute, and improve change control, design controls, and validation throughout the lifecycle of a registered drug.

Examine the procedure of changes within regulatory affairs for CMC, outlining how changes are handled in a regulatory context.